Cargando…
Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration
Ensuring genome safety during gene editing is crucial for clinical translation of the high-efficient CRISPR-Cas9 toolbox. Therefore, the undesired events including chromosomal translocations, vector integrations, and large deletions arising during therapeutic gene editing remain to be adequately add...
Autores principales: | Yin, Jianhang, Fang, Kailun, Gao, Yanxia, Ou, Liqiong, Yuan, Shaopeng, Xin, Changchang, Wu, Weiwei, Wu, Wei-wei, Hong, Jiaxu, Yang, Hui, Hu, Jiazhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780342/ https://www.ncbi.nlm.nih.gov/pubmed/36550137 http://dx.doi.org/10.1038/s41467-022-35640-4 |
Ejemplares similares
-
Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption
por: Xin, Changchang, et al.
Publicado: (2022) -
PEM-seq comprehensively quantifies DNA repair outcomes during gene-editing and DSB repair
por: Liu, Yang, et al.
Publicado: (2022) -
The origin of unwanted editing byproducts in gene editing: Origin of unwanted editing byproducts in gene editing
por: Yin, Jianhang, et al.
Publicado: (2022) -
In-depth assessment of the PAM compatibility and editing activities of Cas9 variants
por: Zhang, Weiwei, et al.
Publicado: (2021) -
Optimizing genome editing strategy by primer-extension-mediated sequencing
por: Yin, Jianhang, et al.
Publicado: (2019)